Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginqvit
- Development stage
- Unknown
- Lead developer
- Sanrey Therapeutics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ginqvit is a combination nutraceutical tablet developed by Sanrey Therapeutics, formulated to support cognitive health, memory maintenance, and overall neurological function. It contains Ginkgo biloba extract (120 mg), Coenzyme Q10 (10 mg), 5-hydroxytryptophan (5-HTP, 20 mg), beta-carotene (2 mg), L-glutathione (10 mg), and 22 essential micronutrients (vitamins and minerals). Ginkgo biloba is traditionally used to enhance cerebral blood flow and cognitive performance, while Coenzyme Q10 and L-glutathione provide antioxidant protection against oxidative stress in neural tissues. 5-HTP serves as a precursor to serotonin, supporting mood and neurotransmitter balance.
- Brand names
- Ginqvit
Beyond the preview
Go deeper on Ginqvit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ginqvit.